AzTrials
AzTrials

Upper Extremity ProblemNCT05931133

Urdu Translation and Validation of Michigan Hand Outcome Questionnaire

An observational study of Upper Extremity Problem, run by Riphah International University at 1 site in Pakistan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Aim of this study to provide a urdu version of Michigan Hand Outcome Questionnaire, that will be more understandable for Pakistani People. Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Upper Extremity Problem
How many people
140 participants
Where
1 sitePakistan
Study dates
1 Jul 2023to 1 Dec 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: All the participants with upper limb and hand disorders will be required to fill the urdu version of michigan hand outcome questionnaire.

Who may be able to join

  • • Patients with conditions and diseases of the Hand and the Upper extremity (arthritis, trauma etc.).
  • Both genders of age 18 and over
  • Patients who are willing to fill study questionnaires.

Who cannot join

  • • Unable to read or write in Urdu
  • People with cognitive dysfunction
  • People with Any neurological disorder
  • Unable to fill questionnaire independently

Trial locations and contacts

1 site in 1 country.

imran amjad, phd contact

03324390125

imran.amjad@riphah.edu.pk

Pakistan1 site
  • District Health quarter jhang

    Jhang, Punjab Province, 35200

    Saba Rafique, Masters, +923034045433, saba.rafique@riphah.edu.pk

    Alishfa Zahoor, MS-OMPT

Other trials in Pakistan

About this study

Aim of this study to provide a urdu version of Michigan Hand Outcome Questionnaire, that will be more understandable for Pakistani People.

Read the detailed description

Because of these unique qualities, the MHQ has become one of widely used tools by the clinicians to assess quality-of-life relevant to functioning of hands and upper limb. It has also been translated to many other languages from the original English version for an easy understanding and adaptation into the local population. despite being its availability in approximately 20 different languages., the Urdu translation of this questionnaire has not yet been published anywhere. Urdu is Pakistan's official language, and the majority of Pakistanis are unable to understand this subjective assessment questionnaire originally written in English. It is required to translate the questionnaire into Urdu for Pakistanis people as the upper limb disorders are one of the most prevalent musculoskeletal disorders in Pakistan. Urdu translation of Michigan Hand Outcomes Questionnaire will help the Pakistan population with hand disorders to describe their pain or disability experience clearly. The Clinical physiotherapists of Pakistan can be capable of capturing the subjective health states of Pakistani patients with hand disorders more conveniently using the Urdu translated MHQ.

Being tested
NO INTERVENTION
Keywords
URDU VERSION, MICHIGAN HAND OUTCOME QUESTIONAIRE

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • NO INTERVENTIONOther

    NO INTERVENTION WILL BE GIVEN

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Each question of Urdu version of Michigan hand outcome questionnaire

    AS its a validity and reliability study so each question of questionnaire will be outcome

    Measured: 6-8 weeks

Secondary outcomes (1)
  1. Each question of Urdu version of SF-36 questionnaire

    AS its a validity and reliability study so each question of questionnaire will be outcome

    Measured: 6-8 Weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jul 2023
  2. Study start1 Jul 2023 (estimated)
  3. Primary completion1 Jul 2023 (estimated)
  4. Study completion1 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
140 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05931133
Sponsor's protocol ID
REC/0029 Alishfa zahoor
Status last verified
Jun 2023
First submitted
26 Jun 2023
Last updated
5 Jul 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Chung KC, Pillsbury MS, Walters MR, Hayward RA. Reliability and validity testing of the Michigan Hand Outcomes Questionnaire. J Hand Surg Am. 1998 Jul;23(4):575-87. doi: 10.1016/S0363-5023(98)80042-7.

    PubMed 9708370
  • Chung KC, Hamill JB, Walters MR, Hayward RA. The Michigan Hand Outcomes Questionnaire (MHQ): assessment of responsiveness to clinical change. Ann Plast Surg. 1999 Jun;42(6):619-22. doi: 10.1097/00000637-199906000-00006.

    PubMed 10382797
  • Blomstrand J, Karlsson J, Fagevik Olsen M, Kjellby Wendt G. The Michigan Hand Outcomes Questionnaire (MHQ-Swe) in patients with distal radius fractures-cross-cultural adaptation to Swedish, validation and reliability. J Orthop Surg Res. 2021 Jul 7;16(1):442. doi: 10.1186/s13018-021-02571-7.

    PubMed 34233700

Questions about this trial

What is this clinical trial studying?

An observational study of Upper Extremity Problem, run by Riphah International University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact imran amjad, phd (03324390125, imran.amjad@riphah.edu.pk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Each question of Urdu version of Michigan hand outcome questionnaire (time frame: 6-8 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05931133, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jul 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in